Shelton Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$372K Sell
6,760
-114
-2% -$6.27K 0.01% 423
2025
Q1
$486K Sell
6,874
-311
-4% -$22K 0.01% 337
2024
Q4
$472K Sell
7,185
-268
-4% -$17.6K 0.01% 360
2024
Q3
$524K Sell
7,453
-148
-2% -$10.4K 0.01% 338
2024
Q2
$626K Buy
+7,601
New +$626K 0.02% 300
2020
Q4
Sell
-13,199
Closed -$1M 733
2020
Q3
$1M Hold
13,199
0.04% 341
2020
Q2
$1.63M Hold
13,199
0.09% 195
2020
Q1
$1.12M Sell
13,199
-210
-2% -$17.7K 0.08% 200
2019
Q4
$1.13M Sell
13,409
-1,900
-12% -$161K 0.06% 225
2019
Q3
$1.03M Hold
15,309
0.06% 219
2019
Q2
$1.31M Buy
15,309
+13,949
+1,026% +$1.19M 0.08% 206
2019
Q1
$15.3K Sell
1,360
-13,949
-91% -$157K 0.06% 269
2018
Q4
$1.3M Hold
15,309
0.09% 187
2018
Q3
$1.49M Hold
15,309
0.08% 195
2018
Q2
$1.44M Buy
15,309
+3,092
+25% +$291K 0.09% 191
2018
Q1
$990K Hold
12,217
0.06% 231
2017
Q4
$1.09M Hold
12,217
0.07% 218
2017
Q3
$1.14M Hold
12,217
0.08% 211
2017
Q2
$1.11M Buy
12,217
+1,591
+15% +$145K 0.08% 218
2017
Q1
$933K Buy
10,626
+1,677
+19% +$147K 0.06% 232
2016
Q4
$741K Hold
8,949
0.06% 274
2016
Q3
$828K Hold
8,949
0.07% 241
2016
Q2
$696K Sell
8,949
-2,950
-25% -$229K 0.06% 278
2016
Q1
$981K Buy
11,899
+1,021
+9% +$84.2K 0.09% 198
2015
Q4
$1.14M Buy
10,878
+2,908
+36% +$305K 0.11% 174
2015
Q3
$839K Buy
+7,970
New +$839K 0.09% 198
2015
Q2
Sell
-4,000
Closed -$498K 770
2015
Q1
$498K Sell
4,000
-16,000
-80% -$1.99M 0.05% 380
2014
Q4
$1.81M Sell
20,000
-84,000
-81% -$7.59M 0.21% 98
2014
Q3
$7.51M Hold
104,000
1.01% 12
2014
Q2
$6.47M Buy
104,000
+2,000
+2% +$124K 0.9% 13
2014
Q1
$6.96M Buy
102,000
+4,600
+5% +$314K 1.02% 12
2013
Q4
$6.85M Sell
97,400
-52,600
-35% -$3.7M 1.04% 12
2013
Q3
$10.8M Hold
150,000
1.81% 3
2013
Q2
$8.36M Buy
+150,000
New +$8.36M 1.53% 5